Celgene, Quanticel to develop cancer drugs
As part of the agreement, Celgene, which will commit $45M to Quanticel during alliance term, will acquire an equity stake in Quanticel and will retain an option to
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.